Cytomegalovirus (CMV): Risks for Immunocompromised Individuals and Pregnancy

CMV is a ubiquitous herpesvirus. Primary infection is usually asymptomatic or mononucleosis-like. Latency follows, with periodic reactivation.

High-Risk Groups

  • Immunocompromised: HIV/AIDS (CD4<50), transplant recipients (especially lung, intestine), chemotherapy, high-dose steroids.
  • Fetuses (congenital CMV): Primary maternal infection in pregnancy → placental transfer. Leading infectious cause of sensorineural hearing loss and neurodevelopmental disability.

End-Organ Disease

  • Pneumonitis (diffuse interstitial infiltrates).
  • Retinitis (vision loss; classic in AIDS).
  • Encephalitis, colitis, hepatitis.

Prevention

  • Hand hygiene (critical for caregivers of young children).
  • Safe sex (condoms).
  • CMV-seronegative blood products for seronegative transplant recipients.
  • Antiviral prophylaxis (valganciclovir) in high-risk transplant settings.

Treatment

Ganciclovir/valganciclovir (first-line). Foscarnet/cidofovir for resistant strains. No vaccine yet (several in trials).

Viral Infections - Related Articles